Researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Articles by: NonPerson Geisel Web Service Acct
On Match Day on March 19th, Geisel medical students of the Class of 2021 learned where they’ll spend their residency.
Dartmouth-Hitchcock (D-H) and the Geisel School of Medicine at Dartmouth have appointed Barbara C. Jobst, MD, Dr. med, as the new chair of the Department of Neurology for D-H and Geisel.
The Student National Medical Association invites you to the inaugural celebration of Black History Month this February. All members of the community are invited with events throughout the entire month.
Matias J. Vega MED ’78 has given a lifetime of service to the underserved, dedicating himself to helping individuals and families experiencing homelessness. Now, he’s being recognized for that work with a Martin Luther King Jr. Social Justice Award in Lifetime Achievement from Dartmouth College.
As we prepare for the new year on January 1st, 2021, we thought we’d share some of the most popular Geisel news stories of 2020.
Alan I. Green, MD, the Raymond Sobel Professor of Psychiatry, who served as chair of the Department of Psychiatry at Geisel and Dartmouth-Hitchcock for nearly 18 years, died Thursday, November 26.
Steven L. Bernstein, MD, has been named as the inaugural Chief Research Officer for Dartmouth-Hitchcock (D-H), Associate Dean of Clinical Research at the Geisel School of Medicine at Dartmouth, and Director of the C. Everett Koop Institute at Geisel.
The next Medical Student Grand Rounds will be held via Zoom on November 11 from 5:30 – 7:00 PM. Please RSVP at the link below to receive the Zoom link for the meeting.
A team of researchers led by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has identified mammary basal cells as a contributing source to the development of heterogeneous tumor cell subpopulations and found that activation of the PKA signaling pathway can curtail their emergence, providing opportunities for new therapeutic approaches to breast cancer.